LKT Labs, 288383-20-0, Biologically Active Small Molecules

Sort
View
Show
  • LKT Labs

    Cediranib is a pan-VEGFR inhibitor that displays anticancer chemotherapeutic and anti-angiogenic activities. Cediranib is currently in clinical trials and displays activity against a wide variety of cancers. In an animal model of intestinal cancer, ced Grade: ≥98%